Subtopic Deep Dive
Ferrocene Estrogen Receptor Modulators
Research Guide
What is Ferrocene Estrogen Receptor Modulators?
Ferrocene Estrogen Receptor Modulators (FERMs) are organometallic compounds featuring a ferrocene unit conjugated to selective estrogen receptor modulator (SERM) scaffolds like tamoxifen or raloxifene for breast cancer therapy.
Ferrocifens and hydroxyferrocifens mimic tamoxifen structures with ferrocene replacing phenyl groups (Top et al., 2003, 400 citations). These hybrids show antiproliferative effects on hormone-dependent and independent breast cancer cell lines (Top et al., 2001, 247 citations). Over 10 key papers since 2001 explore their synthesis, binding, and mechanisms.
Why It Matters
FERMs target estrogen receptor-positive breast cancers resistant to tamoxifen via redox activation generating cytotoxic radicals (Wlassoff et al., 2007, 96 citations). They exhibit dual SERM activity, combining antiestrogenic effects with broad cytotoxicity (Top et al., 2001). Jaouen group's ferrocifens advance hybrid metallodrug design for hormone-independent tumors (Hillard et al., 2006, 113 citations). Applications include preclinical testing against MCF-7 and MDA-MB-231 cell lines.
Key Research Challenges
Redox Mechanism Optimization
Balancing ferrocene redox potential for selective H2O2 activation in cancer cells remains challenging (Wlassoff et al., 2007). Top et al. (2003) showed hydroxyferrocifens generate oxidative stress but require tuning for in vivo stability.
ER Binding Selectivity
Achieving SERM-like subtype selectivity (ERα vs ERβ) while retaining cytotoxicity is difficult (Top et al., 2001). Structural modifications like phenol replacement affect potency variably (Pigeon et al., 2008).
In Vivo Pharmacokinetics
Ferrocene conjugates face solubility and metabolism hurdles limiting systemic delivery (Jaouen et al., 2007). Dyson (2007) highlights targeted design needs for organometallic drugs.
Essential Papers
Synthesis, Biochemical Properties and Molecular Modelling Studies of Organometallic Specific Estrogen Receptor Modulators (SERMs), the Ferrocifens and Hydroxyferrocifens: Evidence for an Antiproliferative Effect of Hydroxyferrocifens on both Hormone‐Dependent and Hormone‐Independent Breast Cancer Cell Lines
Siden Top, Anne Vessières, Guy Leclercq et al. · 2003 · Chemistry - A European Journal · 400 citations
Abstract A series of ferrocene derivatives based upon the structure of the antiestrogenic drug tamoxifen or of its active metabolite hydroxytamoxifen has been prepared and named by analogy ferrocif...
Studies on organometallic selective estrogen receptor modulators. (SERMs) Dual activity in the hydroxy-ferrocifen series
Siden Top, Anne Vessières, Claude Cabestaing et al. · 2001 · Journal of Organometallic Chemistry · 247 citations
Enzyme inhibition by metal complexes: concepts, strategies and applications
K.J. Kilpin, Paul J. Dyson · 2013 · Chemical Science · 232 citations
Metal complexes are increasingly being used to inhibit enzymes. The reasons for this increased interest arise from the special features that metal complexes offer, e.g. the facile construction of 3...
Systematic Design of a Targeted Organometallic Antitumour Drug in Pre-clinical Development
Paul J. Dyson · 2007 · CHIMIA International Journal for Chemistry · 220 citations
Organometallic ruthenium compounds that are effective anticancer and antimetastasis agents are currently under intensive investigation (see also the article by Peter Sadler in this issue). This art...
On the Discovery, Biological Effects, and Use of Cisplatin and Metallocenes in Anticancer Chemotherapy
Santiago Gómez‐Ruiz, Danijela Maksimović‐Ivanić, Sanja Mijatović et al. · 2012 · Bioinorganic Chemistry and Applications · 179 citations
The purpose of this paper is to summarize mode of action of cisplatin on the tumor cells, a brief outlook on the metallocene compounds as antitumor drugs as well as the future tendencies for the us...
Ferrocifens and Ferrocifenols as New Potential Weapons against Breast Cancer
Nguyễn Thị Vân Anh, Anne Vessières, Elizabeth A. Hillard et al. · 2007 · CHIMIA International Journal for Chemistry · 166 citations
Depending on the presence or absence of the estrogen receptor in the cells, breast cancer today is often treated by endocrine therapy (tamoxifen) or chemotherapy, respectively. We present now a new...
A Series of Unconjugated Ferrocenyl Phenols: Prospects as Anticancer Agents
Elizabeth A. Hillard, Anne Vessières, Franck Le Bideau et al. · 2006 · ChemMedChem · 113 citations
Abstract We recently reported that a ferrocenyl diphenol butene derivative showed a very strong cytotoxic effect on both hormone‐dependent and ‐independent breast cancer cell lines. In order to obt...
Reading Guide
Foundational Papers
Start with Top et al. (2003, 400 citations) for ferrocifen synthesis and cell line data; Top et al. (2001, 247 citations) for dual activity mechanisms.
Recent Advances
Hillard et al. (2006, 113 citations) on ferrocenyl phenols; Pigeon et al. (2008, 72 citations) on aniline modifications enhancing cytotoxicity.
Core Methods
McMurry coupling for synthesis; molecular modeling for ER binding (Top et al., 2003); MTT assays for IC50 on MCF-7/MDA-MB-231 cells; cyclic voltammetry for redox potentials.
How PapersFlow Helps You Research Ferrocene Estrogen Receptor Modulators
Discover & Search
Research Agent uses searchPapers('ferrocifens hydroxyferrocifens breast cancer') to retrieve Top et al. (2003, 400 citations), then citationGraph reveals Jaouen group clusters and findSimilarPapers uncovers Hillard et al. (2006). exaSearch handles niche queries like 'ferrocene tamoxifen conjugates ER modulation'.
Analyze & Verify
Analysis Agent applies readPaperContent on Top et al. (2003) to extract binding affinity data (Ki values), verifyResponse with CoVe cross-checks claims against Vessières et al. (2001), and runPythonAnalysis plots dose-response curves from MCF-7 cell data using matplotlib for IC50 comparisons. GRADE grading scores evidence strength for antiproliferative claims.
Synthesize & Write
Synthesis Agent detects gaps in redox mechanism studies across ferrocifens, flags contradictions in ER selectivity (Top 2001 vs Pigeon 2008), while Writing Agent uses latexEditText for compound structures, latexSyncCitations for 10+ Jaouen papers, and latexCompile for review manuscripts. exportMermaid visualizes SAR relationships.
Use Cases
"Extract IC50 values from ferrocifens papers and plot vs tamoxifen"
Research Agent → searchPapers → Analysis Agent → readPaperContent (Top 2003, Hillard 2006) → runPythonAnalysis (pandas data extraction, matplotlib bar plot) → researcher gets CSV of IC50s and publication-ready figure.
"Write LaTeX section on ferrocifen synthesis with citations"
Research Agent → citationGraph (Jaouen cluster) → Synthesis Agent → gap detection → Writing Agent → latexEditText (schemes) → latexSyncCitations (Top 2003 etc.) → latexCompile → researcher gets formatted PDF section.
"Find open-source code for ferrocene docking simulations"
Research Agent → searchPapers('ferrocene ER docking') → paperExtractUrls → paperFindGithubRepo → githubRepoInspect → researcher gets verified AutoDock scripts linked to Top 2003 modeling.
Automated Workflows
Deep Research workflow scans 50+ ferrocene papers via searchPapers → citationGraph → structured report on SERM evolution (Top 2001-2008). DeepScan's 7-step chain verifies redox claims: readPaperContent (Wlassoff 2007) → CoVe → runPythonAnalysis on H2O2 data. Theorizer generates hypotheses on ferrocene-ER subtype selectivity from Jaouen literature.
Frequently Asked Questions
What defines Ferrocene Estrogen Receptor Modulators?
FERMs are ferrocene-tamoxifen hybrids (ferrocifens) acting as SERMs with dual antiestrogenic/cytotoxic activity (Top et al., 2003).
What are key synthesis methods?
McMurry coupling replaces phenyl with ferrocene in tamoxifen scaffold, yielding ferrocifens and hydroxyferrocifens (Top et al., 2003; Top et al., 2001).
What are the most cited papers?
Top et al. (2003, 400 citations) on ferrocifens' properties; Top et al. (2001, 247 citations) on dual SERM activity.
What open problems exist?
In vivo efficacy, ER subtype selectivity, and redox tuning for clinical translation (Pigeon et al., 2008; Dyson, 2007).
Research Ferrocene Chemistry and Applications with AI
PapersFlow provides specialized AI tools for Chemistry researchers. Here are the most relevant for this topic:
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Paper Summarizer
Get structured summaries of any paper in seconds
Deep Research Reports
Multi-source evidence synthesis with counter-evidence
Code & Data Discovery
Find datasets, code repositories, and computational tools
See how researchers in Chemistry use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Ferrocene Estrogen Receptor Modulators with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Chemistry researchers